Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Colorectal cancer | R-HSA-4791275 | map05210 | mecamylamine | 446378 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | loracarbef | 54670067 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | loracarbef | 54670067 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | loracarbef | 54670067 | drug-path |
| Long-term potentiation | R-HSA-9620244 | map04720 | sulfametoxydiazine | 5326 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | sulfametoxydiazine | 5326 | drug-path |
| Long-term depression | R-HSA-9620244 | map04730 | sulfametoxydiazine | 5326 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | sulfametoxydiazine | 5326 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | sulfametoxydiazine | 5326 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | sulfametoxydiazine | 5326 | drug-path |
| Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | sulfametoxydiazine | 5326 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | sulfametoxydiazine | 5326 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | Prestwick-1082 | None | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | Prestwick-1082 | None | drug-path |
| Amyotrophic lateral sclerosis (ALS) | Q8NDH6-2 | 0 | Prestwick-1082 | None | drug-path |
| Pancreatic cancer | R-HSA-9700206 | map05212 | Prestwick-1082 | None | drug-path |
| Prostate cancer | R-HSA-2990872 | map05215 | Prestwick-1082 | None | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | Prestwick-1082 | None | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | Prestwick-1082 | None | drug-path |
| Non-small cell lung cancer | R-HSA-5619066 | map05223 | Prestwick-1082 | None | drug-path |